NCT02004860View on ClinicalTrials.gov

Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Severe Seborrheic Dermatitis
Interventions
DRUG

Protopic (R)

Protopic® 0.1% ointment - 2 applications per week for 6 months

DRUG

Mycoster (R)

Mycoster 1% - 2 applications per week for 6 months

Trial Locations (1)

76031

Rouen University Hospital, Rouen

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT02004860 - Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis | Biotech Hunter | Biotech Hunter